Abivax abstract on obefazimod phase 2b results selected for moderated poster presentation at UEG Week 2022Obefazimod (ABX464) interim 48-week safety and efficacy analysis from the ongoing phase 2b maintenance study in moderate-to-severe ulcerative colitis (UC)…
FedEx works with customers to evaluate offering end-to-end sustainability for our supply chains through options such as carbon neutral shipping offerings and sustainable packaging solutions. We assist customers in optimizing package size and weight to…
Today, the Colorado Department of the Treasury announced the launch of its new investor relations (IR) website, www.stateofcoloradofinancings.bondlink.com, to enhance transparency. The new IR website is focused on potential investors and is accessible to all who…
RADNOR, PA / ACCESSWIRE / September 14, 2022 / BM Technologies, Inc. (NYSE American:BMTX), one of the largest digital banking platforms and Banking-as-a-Service (BaaS) providers, announced that Luvleen Sidhu, Chair, CEO, and Founder, was selected as a…
MIDDLETOWN, DE / ACCESSWIRE / September 15, 2022 / The Coin Return Group, a blockchain investigation and security firm, is pleased to announce that they are now exclusively offering blockchain investigations and security consulting in 2022.…
PORT ST. LUCIE, FL / ACCESSWIRE / September 15, 2022 / Altitude International Holdings, Inc. (OTC Pink:ALTD) (“Altitude” or the “Company’), a diversified, vertically integrated holding company focused on performance-based businesses, has engaged international investor relations…
VANCOUVER, BC / ACCESSWIRE / September 15, 2022 / Torq Resources Inc. (TSXV:TORQ)(OTCQX:TRBMF) (“Torq” or the “Company”) is pleased to announce that it has closed the C$15 million non-brokered private placement with a wholly owned affiliate…
NEW YORK, NY / ACCESSWIRE / September 7, 2022 / Driver Technologies, Inc., an AI-based mobility tech company that delivers a safer driving experience, and Marble, an all-in-one insurance management tool and rewards platform, today announced a…
BOSTON, MA / ACCESSWIRE / September 8, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that management is scheduled to…
BROSSARD, QC / ACCESSWIRE / September 8, 2022 / G Mining Ventures Corp. (“GMIN” or the “Corporation“) (TSXV:GMIN)(OTCQX:GMINF) announces that, in accordance with the Corporation’s Stock Option Plan, the Board of Directors has granted, as of…